146
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Tropisetron, Ondansetron, and Granisetron for Control of Chemotherapy-Induced Emesis in Turkish Cancer Patients: A Comparison of Efficacy, Side-Effect Profile, and Cost

, M.D. & , M.D.
Pages 135-139 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Giovana Paula Rezende Simino, Lays Pires Marra, Eli Iola Gurgel de Andrade, Francisco de Assis Acúrcio, Ilka Afonso Reis, Vânia Eloisa De Araújo & Mariângela Leal Cherchiglia. (2016) Efficacy, safety and effectiveness of ondansetron compared to other serotonin-3 receptor antagonists (5-HT3RAs) used to control chemotherapy-induced nausea and vomiting: systematic review and meta-analysis. Expert Review of Clinical Pharmacology 9:9, pages 1183-1194.
Read now

Articles from other publishers (12)

Vanessa Piechotta, Anne Adams, Madhuri Haque, Benjamin Scheckel, Nina Kreuzberger, Ina Monsef, Karin Jordan, Kathrin Kuhr & Nicole Skoetz. (2021) Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis. Cochrane Database of Systematic Reviews 2022:1.
Crossref
Rachel Huddart, Russ B. Altman & Teri E. Klein. (2019) PharmGKB summary. Pharmacogenetics and Genomics 29:4, pages 91-97.
Crossref
Silvia Sommariva, Benedetta Pongiglione & Rosanna Tarricone. (2016) Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: A systematic review. Critical Reviews in Oncology/Hematology 99, pages 13-36.
Crossref
Kevin Yi-Lwern Yap, Xiu Hui Low & Alexandre Chan. (2012) Exploring Chemotherapy-Induced Toxicities through Multivariate Projection of Risk Factors: Prediction of Nausea and Vomiting. Toxicological Research 28:2, pages 81-91.
Crossref
Sanjeev Balu, Deborah Buchner, Chris Craver & Julie Gayle. (2011) Palonosetron Versus Other 5-HT3 Receptor Antagonists for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer on Chemotherapy in a Hospital Outpatient Setting. Clinical Therapeutics 33:4, pages 443-455.
Crossref
D. A. Perwitasari, Hans Gelderblom, Jarir Atthobari, Mustofa Mustofa, Iwan Dwiprahasto, Johan W. R. Nortier & Henk-Jan Guchelaar. (2011) Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics. International Journal of Clinical Pharmacy 33:1, pages 33-43.
Crossref
Eric S Hsu. (2010) A Review of Granisetron, 5-Hydroxytryptamine3 Receptor Antagonists, and Other Antiemetics. American Journal of Therapeutics 17:5, pages 476-486.
Crossref
Qiuhai Qian, Wenhui Chen, Wang Yue, Zhihong Yang, Zhantao Liu & Weibin Qian. (2010) Antiemetic effect of Xiao-Ban-Xia-Tang, a Chinese medicinal herb recipe, on cisplatin-induced acute and delayed emesis in minks. Journal of Ethnopharmacology 128:3, pages 590-593.
Crossref
Qian-Mei Zhou, Hui Zhang, Yi-Yu Lu, Xiu-Feng Wang & Shi-Bing Su. (2009) Curcumin reduced the side effects of mitomycin C by inhibiting GRP58-mediated DNA cross-linking in MCF-7 breast cancer xenografts. Cancer Science 100:11, pages 2040-2045.
Crossref
Qiu-hai Qian, Wang Yue, Yao-xia Wang, Zhi-hong Yang, Zhan-tao Liu & Wen-hui Chen. (2009) Gingerol inhibits cisplatin-induced vomiting by down regulating 5-hydroxytryptamine, dopamine and substance P expression in minks. Archives of Pharmacal Research 32:4, pages 565-573.
Crossref
Zhaocai Yu, Wenchao Liu, Ling Wang, Houjie Liang, Ying Huang, Xiaoming Si, Helong Zhang, Duhu Liu & Hongmei Zhang. (2008) The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial. Supportive Care in Cancer 17:1, pages 99-102.
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.